Renovaro Biosciences Stock Price Prediction
| RENB Stock | 0.76 0.15 24.59% |
Oversold Vs Overbought
43
Oversold | Overbought |
Using Renovaro Biosciences hype-based prediction, you can estimate the value of Renovaro Biosciences from the perspective of Renovaro Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Renovaro Biosciences to buy its stock at a price that has no basis in reality. In that case, they are not buying Renovaro because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Renovaro Biosciences after-hype prediction price | USD 1.04 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Renovaro |
Renovaro Biosciences After-Hype Price Prediction Density Analysis
As far as predicting the price of Renovaro Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Renovaro Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Renovaro Biosciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Renovaro Biosciences Estimiated After-Hype Price Volatility
In the context of predicting Renovaro Biosciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Renovaro Biosciences' historical news coverage. Renovaro Biosciences' after-hype downside and upside margins for the prediction period are 0.05 and 11.05, respectively. We have considered Renovaro Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Renovaro Biosciences is out of control at this time. Analysis and calculation of next after-hype price of Renovaro Biosciences is based on 3 months time horizon.
Renovaro Biosciences Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Renovaro Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Renovaro Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Renovaro Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.06 | 10.01 | 0.28 | 0.30 | 7 Events / Month | 7 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.76 | 1.04 | 36.84 |
|
Renovaro Biosciences Hype Timeline
Renovaro Biosciences is at this time traded for 0.76. The entity has historical hype elasticity of 0.28, and average elasticity to hype of competition of -0.3. Renovaro is estimated to increase in value after the next headline, with the price projected to jump to 1.04 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 36.84%, whereas the daily expected return is at this time at 1.06%. The volatility of related hype on Renovaro Biosciences is about 3512.28%, with the expected price after the next announcement by competition of 0.46. Renovaro Biosciences currently holds 3.79 M in liabilities. Note, when we think about Renovaro Biosciences' use of debt, we should always consider it together with its cash and equity.Given the investment horizon of 90 days the next estimated press release will be in about 7 days. Check out Renovaro Biosciences Basic Forecasting Models to cross-verify your projections.Renovaro Biosciences Related Hype Analysis
Having access to credible news sources related to Renovaro Biosciences' direct competition is more important than ever and may enhance your ability to predict Renovaro Biosciences' future price movements. Getting to know how Renovaro Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Renovaro Biosciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ALNT | Allient | 0.04 | 8 per month | 2.40 | 0.09 | 5.25 | (4.45) | 11.31 | |
| MIND | Mind Technology | (0.07) | 8 per month | 2.17 | (0.04) | 4.40 | (4.22) | 13.68 | |
| VMD | Viemed Healthcare | (0.03) | 10 per month | 1.67 | 0.06 | 3.30 | (2.76) | 10.98 | |
| ARW | Arrow Electronics | (1.63) | 9 per month | 0.00 | (0.13) | 2.56 | (1.98) | 15.96 | |
| CPIX | Cumberland Pharmaceuticals | 0.08 | 9 per month | 2.37 | (0.01) | 4.65 | (4.69) | 10.64 | |
| PLTK | Playtika Holding Corp | (0.03) | 9 per month | 1.24 | 0.03 | 2.33 | (2.19) | 7.19 | |
| CTLT | Catalent | (0.06) | 9 per month | 0.39 | (0.16) | 1.12 | (0.69) | 3.39 | |
| SCSC | ScanSource | (0.58) | 8 per month | 0.00 | (0.06) | 2.52 | (2.89) | 15.95 |
Renovaro Biosciences Additional Predictive Modules
Most predictive techniques to examine Renovaro price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Renovaro using various technical indicators. When you analyze Renovaro charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Renovaro Biosciences Predictive Indicators
The successful prediction of Renovaro Biosciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Renovaro Biosciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Renovaro Biosciences based on analysis of Renovaro Biosciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Renovaro Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Renovaro Biosciences's related companies. | 2023 | 2024 (projected) | Graham Number | 5.08 | 3.86 | Receivables Turnover | 0.0554 | 0.0492 |
Story Coverage note for Renovaro Biosciences
The number of cover stories for Renovaro Biosciences depends on current market conditions and Renovaro Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Renovaro Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Renovaro Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Renovaro Biosciences Short Properties
Renovaro Biosciences' future price predictability will typically decrease when Renovaro Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Renovaro Biosciences often depends not only on the future outlook of the potential Renovaro Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Renovaro Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 96.2 M | |
| Cash And Short Term Investments | 220.5 K |
Complementary Tools for Renovaro Stock analysis
When running Renovaro Biosciences' price analysis, check to measure Renovaro Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Renovaro Biosciences is operating at the current time. Most of Renovaro Biosciences' value examination focuses on studying past and present price action to predict the probability of Renovaro Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Renovaro Biosciences' price. Additionally, you may evaluate how the addition of Renovaro Biosciences to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |